KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors
Sotorasib showed encouraging anticancer activity in patients with heavily pretreated advanced solid tumors harboring the <i>KRAS</i> p.G12C mutation. Grade 3 or 4 treatment-rela...